Skip to main content
SpringerLink
Log in

Choosing the Ideal Hemodynamic Therapy in Acute Right and Left Heart Failure

  • Chapter
Hemodynamic Monitoring

Part of the book series: Lessons from the ICU ((LEICU))

  • 3948 Accesses

Abstract

Management of acute heart failure (AHF) is highly challenging. This lies in part in the complexity and heterogeneity of this possibly life-threatening clinical syndrome, but also in the urgent need for intervention to improve patient status and outcome.

This chapter will survey acute right and left ventricular heart failure with focus on therapy. Important features are displayed in the tables, and Suggested Reading can be found at the end of the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. https://doi.org/10.1002/ejhf.592. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  2. Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 2016;42(2):147–63. https://doi.org/10.1007/s00134-015-4041-5. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  3. Harjola VP, Mebazaa A, Celutkiene J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18(3):226–41. https://doi.org/10.1002/ejhf.478. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  4. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S. https://doi.org/10.1016/j.jacc.2004.02.037. [published Online First: Epub Date].

    Article  Google Scholar 

  5. Hilfiker-Kleiner D, Schieffer E, Meyer GP, et al. Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists. Dtsch Arztebl Int. 2008;105(44):751–6. https://doi.org/10.3238/arztebl.2008.0751. [published Online First: Epub Date].

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, et al. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015;36(18):1090–7. https://doi.org/10.1093/eurheartj/ehv009. [published Online First: Epub Date].

    Article  PubMed  PubMed Central  Google Scholar 

  7. Arany Z, Elkayam U. Peripartum Cardiomyopathy. Circulation. 2016;133(14):1397–409. https://doi.org/10.1161/CIRCULATIONAHA.115.020491. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  8. Chaliki HP, Mohty D, Avierinos JF, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation. 2002;106(21):2687–93.

    Article  PubMed  Google Scholar 

  9. Kurisu S, Sato H, Kawagoe T, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143(3):448–55.

    Article  Google Scholar 

  10. Zannad F, Mebazaa A, Juilliere Y, et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail. 2006;8(7):697–705. https://doi.org/10.1016/j.ejheart.2006.01.001. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  11. Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med. 1992;21(6):669–74.

    Article  CAS  PubMed  Google Scholar 

  12. Maisel AS, Peacock WF, McMullin N, et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008;52(7):534–40. https://doi.org/10.1016/j.jacc.2008.05.010. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  13. Peacock WF, Emerman C, Costanzo MR, et al. Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail. 2009;15(6):256–64. https://doi.org/10.1111/j.1751-7133.2009.00112.x. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  14. Emerman CL. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Rev Cardiovasc Med. 2003;4(Suppl 7):S13–20.

    PubMed  Google Scholar 

  15. Matsue Y, Damman K, Voors AA, et al. Time-to-Furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(25):3042–51. https://doi.org/10.1016/j.jacc.2017.04.042. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  16. Gray A, Goodacre S, Newby DE, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359(2):142–51. https://doi.org/10.1056/NEJMoa0707992. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  17. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351(9100):389–93. https://doi.org/10.1016/S0140-6736(97)08417-1. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  18. Fala L. Entresto (Sacubitril/Valsartan): first-in-class angiotensin receptor neprilysin inhibitor FDA approved for patients with heart failure. Am Health Drug Benefits. 2015;8(6):330–4.

    PubMed  PubMed Central  Google Scholar 

  19. Solomon SD, Claggett B, Desai AS, et al. Influence of ejection fraction on outcomes and efficacy of Sacubitril/Valsartan (LCZ696) in heart failure with reduced ejection fraction: the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF) trial. Circ Heart Fail. 2016;9(3):e002744. https://doi.org/10.1161/circheartfailure.115.002744. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  20. Ural D, Çavuşoğlu Y, Eren M, et al. Diagnosis and management of acute heart failure. Anatol J Cardiol. 2016;15(11):860–89. https://doi.org/10.5152/AnatolJCardiol.2015.6567. [published Online First: Epub Date].

    Article  PubMed Central  Google Scholar 

  21. Park JH, Balmain S, Berry C, et al. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart. 2010;96(7):533–8. https://doi.org/10.1136/hrt.2009.175257. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  22. Miro O, Gil V, Martin-Sanchez FJ, et al. Morphine use in the ED and outcomes of patients with acute heart failure: a propensity score-matching analysis based on the EAHFE registry. Chest. 2017; https://doi.org/10.1016/j.chest.2017.03.037. [published Online First: Epub Date].

  23. ter Maaten JM, Valente MA, Damman K, et al. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184–92. https://doi.org/10.1038/nrcardio.2014.215. [published Online First: Epub Date].

    Article  CAS  Google Scholar 

  24. Channer KS, McLean KA, Lawson-Matthew P, et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994;71(2):146–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Knauf H, Mutschler E. Functional state of the nephron and diuretic dose-response--rationale for low-dose combination therapy. Cardiology. 1994;84(Suppl 2):18–26.

    Article  PubMed  Google Scholar 

  26. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297(12):1319–31. https://doi.org/10.1001/jama.297.12.1319. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  27. Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296–304. https://doi.org/10.1056/NEJMoa1210357. [published Online First: Epub Date].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mebazaa A, Longrois D, Metra M, et al. Agents with vasodilator properties in acute heart failure: how to design successful trials. Eur J Heart Fail. 2015;17(7):652–64. https://doi.org/10.1002/ejhf.294. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  29. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69. https://doi.org/10.1093/eurjhf/hfs105. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  30. Levy P, Compton S, Welch R, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007;50(2):144–52. https://doi.org/10.1016/j.annemergmed.2007.02.022. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  31. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. https://doi.org/10.1016/j.jacc.2013.05.019. [published Online First: Epub Date].

    Article  Google Scholar 

  32. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725–36. https://doi.org/10.1093/eurheartj/ehl193.

    Article  PubMed  Google Scholar 

  33. Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–9. https://doi.org/10.1002/ejhf.260. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  34. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625–34. https://doi.org/10.1056/NEJM199908263410901. [published Online First: Epub Date].

    Article  CAS  Google Scholar 

  35. Authors/Task Force m, Windecker S, Kolh P, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619. https://doi.org/10.1093/eurheartj/ehu278. [published Online First: Epub Date].

    Article  Google Scholar 

  36. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369(23):2197–206. https://doi.org/10.1056/NEJMoa1310519. [published Online First: Epub Date].

    Article  CAS  Google Scholar 

  37. Thiele H, Ohman EM, Desch S, et al. Management of cardiogenic shock. Eur Heart J. 2015;36(20):1223–30. https://doi.org/10.1093/eurheartj/ehv051. [published Online First: Epub Date].

    Article  Google Scholar 

  38. Arrigo M, Mebazaa A. Understanding the differences among inotropes. Intensive Care Med. 2015;41(5):912–5. https://doi.org/10.1007/s00134-015-3659-7. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  39. Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med. 2011;39(3):450–5. https://doi.org/10.1097/CCM.0b013e3181ffe0eb. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  40. Ribeiro RA, Restelatto LMF. Increased mortality with the use of adrenaline in shock: the evidence is still limited. Crit Care. 2016;20 https://doi.org/10.1186/s13054-016-1465-4. [published Online First: Epub Date].

  41. Pirracchio R, Parenica J, Resche Rigon M, et al. The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One. 2013;8(8):e71659. https://doi.org/10.1371/journal.pone.0071659. [published Online First: Epub Date].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89. https://doi.org/10.1056/NEJMoa0907118. [published Online First: Epub Date].

    Article  Google Scholar 

  43. Levy B, Bastien O, Karim B, et al. Experts' recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care. 2015;5(1):52. https://doi.org/10.1186/s13613-015-0052-1. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  44. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795–815. https://doi.org/10.1007/s00134-014-3525-z. [published Online First: Epub Date].

    Article  PubMed  PubMed Central  Google Scholar 

  45. Davidson J, Baumgariner F, Omari B, et al. Intra-aortic balloon pump: indications and complications. J Natl Med Assoc. 1998;90(3):137–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382(9905):1638–45. https://doi.org/10.1016/S0140-6736(13)61783-3. [published Online First: Epub Date].

    Article  Google Scholar 

  47. Thiele H, Schuler G, Neumann FJ, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012;163(6):938–45. https://doi.org/10.1016/j.ahj.2012.03.012. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  48. American College of Emergency P, Society for Cardiovascular A, Interventions, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140. https://doi.org/10.1016/j.jacc.2012.11.019. [published Online First: Epub Date].

    Article  Google Scholar 

  49. Meune C, Spaulding C, Mahe I, et al. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf. 2003;26(13):975–81.

    Article  CAS  PubMed  Google Scholar 

  50. Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69, 69a-69k. https://doi.org/10.1093/eurheartj/ehu283. [published Online First: Epub Date].

    Article  CAS  Google Scholar 

  51. James A, Veean S, Keshavamurthy JH, et al. Fibrinolytic administration via EKOS catheter used in pulmonary embolism. Lung India. 2017;34(3):273–4. https://doi.org/10.4103/lungindia.lungindia_342_16. [published Online First: Epub Date].

    Article  PubMed  PubMed Central  Google Scholar 

  52. Fuller TJ, Paprzycki CM, Zubair MH, et al. Initial experiences with endovascular management of submassive pulmonary embolism: is it safe? Ann Vasc Surg. 2017;38:158–63. https://doi.org/10.1016/j.avsg.2016.09.002. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  53. Green EM, Givertz MM. Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep. 2012;9(3):228–35. https://doi.org/10.1007/s11897-012-0104-x. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  54. Gayat E, Mebazaa A. Pulmonary hypertension in critical care. Curr Opin Crit Care. 2011;17(5):439–48. https://doi.org/10.1097/MCC.0b013e32834a7619. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  55. Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184(10):1114–24. https://doi.org/10.1164/rccm.201104-0662CI. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  56. Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc. 2014;11(5):811–22. https://doi.org/10.1513/AnnalsATS.201312-446FR. [published Online First: Epub Date].

    Article  PubMed  PubMed Central  Google Scholar 

  57. Bowers TR, O'Neill WW, Pica M, et al. Patterns of coronary compromise resulting in acute right ventricular ischemic dysfunction. Circulation. 2002;106(9):1104–9.

    Article  PubMed  Google Scholar 

  58. Laster SB, Shelton TJ, Barzilai B, et al. Determinants of the recovery of right ventricular performance following experimental chronic right coronary artery occlusion. Circulation. 1993;88(2):696–708.

    Article  CAS  PubMed  Google Scholar 

  59. Laster SB, Ohnishi Y, Saffitz JE, et al. Effects of reperfusion on ischemic right ventricular dysfunction. Disparate mechanisms of benefit related to duration of ischemia. Circulation. 1994;90(3):1398–409.

    Article  CAS  PubMed  Google Scholar 

  60. Bodson L, Bouferrache K, Vieillard-Baron A. Cardiac tamponade. Curr Opin Crit Care. 2011;17(5):416–24. https://doi.org/10.1097/MCC.0b013e3283491f27. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  61. Vieillard-Baron A, Price LC, Matthay MA. Acute cor pulmonale in ARDS. Intensive Care Med. 2013;39(10):1836–8. https://doi.org/10.1007/s00134-013-3045-2. [published Online First: Epub Date].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Boissier F, Katsahian S, Razazi K, et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1725–33. https://doi.org/10.1007/s00134-013-2941-9. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  63. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1–44. https://doi.org/10.1093/ejcts/ezs455. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

  64. Group CTS. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429–35. https://doi.org/10.1056/NEJM198706043162301. [published Online First: Epub Date].

    Article  Google Scholar 

  65. Investigators S, Yusuf S, Pitt B, et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293–302. https://doi.org/10.1056/NEJM199108013250501. [published Online First: Epub Date].

    Article  Google Scholar 

  66. Sacks CA, Jarcho JA, Curfman GD. Paradigm shifts in heart-failure therapy--a timeline. N Engl J Med. 2014;371(11):989–91. https://doi.org/10.1056/NEJMp1410241. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  67. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334(21):1349–55. https://doi.org/10.1056/NEJM199605233342101. [published Online First: Epub Date].

    Article  CAS  PubMed  Google Scholar 

  68. Garcia-Prieto J, Villena-Gutierrez R, Gomez M, et al. Neutrophil stunning by metoprolol reduces infarct size. Nat Commun. 2017;8:14780. https://doi.org/10.1038/ncomms14780. [published Online First: Epub Date].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797–804.

    Article  Google Scholar 

  70. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46(1):57–64. https://doi.org/10.1016/j.jacc.2005.03.051. [published Online First: Epub Date].

    Article  PubMed  Google Scholar 

Suggested Reading

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (see reference 1).

    Google Scholar 

  • Harjola, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18:226–41.

    Article  PubMed  Google Scholar 

  • Arrigo, et al. Understanding acute heart failure: pathophysiology and diagnosis. Eur Heart J Suppl. 2016;18(Supplement G):G11–8.

    Article  Google Scholar 

  • Kindermann, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779–92.

    Article  Google Scholar 

  • World Health Organization: division of pulmonary hypertension into 5 groups.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University Hospital of Basel, Basel, Switzerland

    Alexa Hollinger

  2. Hôpitaux Lariboisière Saint Louis University Hospitals, Paris, France

    Alexandre Mebazaa

Authors
  1. Alexa Hollinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexandre Mebazaa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexa Hollinger .

Editor information

Editors and Affiliations

  1. Critical Care Medicine Dept., University of Pittsburgh, Pittsburgh, PA, USA

    Michael R. Pinsky

  2. Bicetre University Hospital, Paris South University, Le Kremlin-Bicêtre, France

    Jean-Louis Teboul

  3. Department of Intensive Care, Erasme University Hospital, Brussels, Belgium

    Jean-Louis Vincent

Rights and permissions

Reprints and permissions

Copyright information

© 2019 European Society of Intensive Care Medicine

About this chapter

Cite this chapter

Hollinger, A., Mebazaa, A. (2019). Choosing the Ideal Hemodynamic Therapy in Acute Right and Left Heart Failure. In: Pinsky, M.R., Teboul, JL., Vincent, JL. (eds) Hemodynamic Monitoring. Lessons from the ICU. Springer, Cham. https://doi.org/10.1007/978-3-319-69269-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-69269-2_32

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-69268-5

  • Online ISBN: 978-3-319-69269-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation